{"id":"F2008B00055","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2002)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":72206,"registerId":"commonwealth-F2008B00055-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2002)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 16 of 2002\n\nI, BRETT ANTHONY LENNON, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration commences on 1 November 2002.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\n“Aminogran Food Supplement”\n\nHydrochlorothiazide\n\nRanitidine Bismuth Citrate and Clarithromycin and Amoxycillin Trihydrate\n\nTenoxicam\n\nDated this 4th day of October 2002.\n\nBRETT ANTHONY LENNON\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1473},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration operates precisely within the scope of section 85(2AA) of the National Health Act 1953, which specifically authorizes the Minister (or delegate) to remove drugs from the Pharmaceutical Benefits Scheme. The instrument does not expand beyond this delegated authority."},"complexity_factors":["Single operative clause with no exceptions or conditions","Limited to four specific enumerated items in the Schedule","No nested definitions or interpretive provisions","Straightforward administrative mechanism under existing delegated authority"],"plain_english_summary":"From 1 November 2002 four medicines — Aminogran food supplement; hydrochlorothiazide; the ranitidine bismuth citrate/clarithromycin/amoxycillin triple therapy; and tenoxicam — were removed from Australia's Pharmaceutical Benefits Scheme. The Assistant Secretary of the Pharmaceutical Benefits Branch, acting on PBAC advice, declared they would no longer be subsidized.\n\nAffected patients must pay the full commercial price for these products or consult their doctor about alternative treatments."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-16-of-2002/documents"}}